Plasma immunoreactive α-atrial natriuretic peptide (IR α-ANP) levels were determined before, and at 5 and 10 min after bolus intravenous administration of morphine (0·15 or 0·30 mg/kg) in 21 otherwise healthy human subjects who underwent elective surgery. Five min after injection IR α-ANP levels had nearly doubled in response to both doses of morphine. At 10 min, plasma IR α-ANP concentrations were lower than at 5 min in the 0·15 mg/kg group suggesting that IR α-ANP levels peak shortly after morphine administration. Morphine has been widely used in the treatment of acute left ventricular failure and ANP is a recently discovered hormone which possesses unique favourable effects in patients with congestive heart failure when administered exogenously. The combination of these data suggests an important potential role for ANP in the mechanism of action of morphine in the treatment of acute left ventricular failure.
De BoldAJBorensteinHBVeressATSonnenbergH.A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats. Life Sci1981; 28: 89–94.
2.
GoetzKL. Physiology and pathophysiology of atrial peptides. Am J Physiol1988; 254: E1–15.
3.
BussienJPBiollazJWaeberBDose-dependent effect of atrial natriuretic peptide on blood pressure, heart rate, and skin blood flow of normal volunteers. J Cardiovasc Pharmacol1984; 8: 216–20.
4.
FaisonEPSieglPKSMorganGWinquistRJ. Regional vasorelaxant selectivity of atrial natriuretic factor in isolated rabbit vessels. Life Sci1985; 37: 1073–9.
5.
BolliPMüllerFBLinderLThe vasodilator potency of atrial natriuretic peptide in man. Circulation1987; 75: 221–8.
6.
ChienYWFrohlichEDTrippodoNC. Atrial natriuretic peptide increases resistance to venous return in rats. Am J Physiol1987; 252: H894–9.
7.
AldermanELBarryWHGrahamAFHarrisonDC. Hemodynamic effects of morphine and pentazocine differ in cardiac patients. N Engl J Med1972; 287; 623–7.
8.
ZelisRMansourEJCaponeRJMasonDT. The cardiovascular effects of morphine: The peripheral capacitance and resistance vessels in human subjects. J Clin Invest1974; 54: 1247–58.
9.
VismaraLALeamanDMZelisR.The effects of morphine on venous tone in patients with acute pulmonary edema. Circulation1976; 54: 335–7.
10.
RieggerAJGKromerEPKochsiekK.Der natriuretische Vorhoffaktor bei schwerer konjestiver Herzinsuffizienz. Dtsch Med Wochenschr1985; 110: 1607–10.
11.
CodyRJAtlasSALaraghJHAtrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest1986; 78: 1362–74.
12.
CroizerIGNichollsMGIkramHHemodynamic effects of atrial peptide infusion in heart failure. Lancet1986; ii: 1242–5.
13.
HorkyKGutkowskaJGarciaRThibaultGGenestJCantinM.Effect of different anesthetics on immunoreactive atrial natriuretic factor concentrations in rat plasma. Biochem Biophys Res Commun1985; 129: 651–7.
14.
De BodoRD. The antidiuretic action of morphine and its mechanism. J Pharmacol Exp Ther1944; 82: 74–85.
15.
DukeHNPickfordMWattJA. Antidiuretic action of morphine. Its site and mode of action in the hypothalamus of the dog. Q J Exp Physiol1951; 36: 149–58.
16.
Huidobro-ToroJP. Antidiuretic effect of beta-endorphin and morphine in the Brattleboro rats. Development of tolerance and physical dependence after chronic morphine treatment. Br J Pharmacol1980; 71: 51–6.
17.
WalkerLAMurphyJC. Effect of renal denervation on the antinatriuretic response to morphine administration in conscious rats. J Pharmacol Exp Ther1986; 237: 799–802.
18.
DaneshSWalkerLA. Effects of central administration of morphine on renal function in conscious rats. J Pharmacol Exp Ther1988; 244: 640–5.
19.
MarchandC.The diuretic and antidiuretic effects of morphine sulphate in rats. Proc Soc Exp Biol Med1970; 133: 1303–6.
20.
WalkerLAMurphyJC. Antinatriuretic effect of acute morphine administration in conscious rats. J Pharmacol Exp Ther1984; 229: 404–8.
21.
LeanderJDHartJCZerbeRL. Kappa agonistinduced diureses: Evidence for stereoselectivity, strain differences, independence of hydration variables and a result of decreased plasma vasopressin levels. J Pharmacol Exp Ther1987; 242: 33–9.
22.
DystraLAGmerekDEWingerGWoodsJH. Kappa opioids in rhesus monkeys. I. Diuresis, sedation, analgesia and discriminate stimulus effects. J Pharmacol Exp Ther1987; 242: 413–20.
23.
BorgesFAndersonJVVoltaCOpioid peptides do not modulate atrial natriuretic peptide or aldosterone release under basal conditions in man. J Endocr1988; 116: 313–7.
